The Procter & Gamble Company (NYSE:PG) Shares Purchased by Calton & Associates Inc.

Calton & Associates Inc. increased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 38.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,536 shares of the company’s stock after purchasing an additional 989 shares during the period. Calton & Associates Inc.’s holdings in Procter & Gamble were worth $612,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Legal & General Group Plc increased its position in shares of Procter & Gamble by 0.6% during the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after acquiring an additional 122,190 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Procter & Gamble by 8.2% in the second quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after acquiring an additional 733,440 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Procter & Gamble by 9.7% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 6,161,507 shares of the company’s stock valued at $999,705,000 after acquiring an additional 545,601 shares during the last quarter. Janus Henderson Group PLC lifted its position in Procter & Gamble by 1.3% in the first quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock valued at $974,914,000 after acquiring an additional 79,665 shares during the last quarter. Finally, Canada Pension Plan Investment Board lifted its position in Procter & Gamble by 3.9% in the second quarter. Canada Pension Plan Investment Board now owns 5,706,199 shares of the company’s stock valued at $941,066,000 after acquiring an additional 216,300 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the sale, the chief executive officer now owns 21,513 shares of the company’s stock, valued at approximately $3,657,210. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock valued at $65,140,718 over the last ninety days. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG stock traded down $0.18 during midday trading on Tuesday, reaching $169.36. 1,833,892 shares of the company were exchanged, compared to its average volume of 6,663,287. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a market cap of $399.71 billion, a P/E ratio of 27.71, a PEG ratio of 3.74 and a beta of 0.41. The company’s 50 day moving average price is $171.82 and its two-hundred day moving average price is $167.33. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.83 EPS. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.69%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on PG shares. Evercore ISI boosted their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Piper Sandler initiated coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. TD Cowen initiated coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Finally, BNP Paribas initiated coverage on shares of Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 price target on the stock. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Read Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.